Scintillation Nanotechnologies

Scintillation Nanotechnologies is a private U.S. life science tools company developing nanoparticle-based scintillation products for detection of radiolabeled compounds in biochemical and cell-based assays. Its core product families, nanoSPA and aquaSCINT, are designed to work in aqueous and live-cell environments and to improve sensitivity, selectivity, and temporal resolution relative to traditional scintillation approaches. The company positions its technology as a research-enabling platform for drug uptake, binding, metabolism, and receptor assay applications, including intracellular measurements that are difficult with legacy methods. In addition to commercial products, the company has received U.S. SBIR support to extend its nanomaterial platform into assays such as small-molecule binding studies in native membranes and GPCR-focused radioassays. Overall, the business appears to be a biotech tools/platform company rather than a therapeutic drug developer.